PMV Pharmaceuticals (PMVP) Cash from Financing Activities (2019 - 2026)
PMV Pharmaceuticals (PMVP) recorded Cash from Financing Activities of $143,000 in Q2 2026, up 38.8% from $103,000 a year earlier.
PMV Pharmaceuticals (PMVP) Cash from Financing Activities (2019 - 2026) Analysis & Trends
On a TTM basis, PMV Pharmaceuticals' Cash from Financing Activities came in at $535,000 as of Jun 30, 2026, up 87.7% year-over-year; for FY2025, it was $505,000, up 61.3% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -72.0% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $313,000 in FY2024 (-99.1%), $35.58 million in FY2023, $958,000 in FY2022 (-52.6%) and $2.02 million in FY2021 (-99.3%).
- Quarterly Cash from Financing Activities has ranged from $6,000 in Q3 2022 to $33.15 million in Q3 2023 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in two of the last four quarters, with growth averaging 24.9%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 672.1% in Q2 2023, against a decline of 99.9% in Q3 2021 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | PMV Pharmaceuticals | 89.28 Mn | -325.89 Mn | - | 143,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Dec 31, 2023 | 288,000.00 |
| Sep 30, 2023 | 33.15 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 276,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 309,000.00 |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 162,000.00 |
| Dec 31, 2020 | -1.36 Mn |
| Sep 30, 2020 | 294.46 Mn |
PMV Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PMVP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();